Skip to main content

Table 3 The calculated TMB and MSI of 3 cases

From: Clinical and genomic features in patients with second primary glioblastoma following first primary renal cell carcinoma

Group

TMB

MSI

TMB (Muts/MB)

(F1CDxa)

TMB (Muts/MB)

(MSK-IMPACTb)

Total number of sites

Number of somatic sites

%

case1-RCC

0.77

0.51

5291

25

0.47

case3-RCC

3.94

2.81

4208

28

0.67

case4-RCC

4.7

3.87

5052

49

0.97

case1-GBM

2.41

1.68

5308

30

0.57

case3-GBM

2.33

1.64

4214

68

1.61

case4-GBM

2.04

1.61

5095

69

1.35

  1. aFoundationOne CDx
  2. bMemorial Sloan Kettering Cancer Center’s Integrated Mutation Profiling of Actionable Cancer Targets
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us